The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Immunocytochemical observations on the distribution of myelin‐associated glycoprotein and myelin basic protein in multiple sclerosis lesions
Abstract
To study the distribution of myelin‐associated glycoprotein (MAG) in human nervous tissue and in multiple sclerosis (MS) lesions, we used paraffin sections and our modification of the peroxidase‐antiperoxidase technique. Sections of MS lesions also were treated with antiserum to basic protein (BP) and with histological stains for axons and myelin sheaths. In tissue from normal developing central nervous system, oligodendroglia, their processes, and newly formed myelin sheaths were intensely stained by MAG antiserum. In adults, MAG was found in periaxonal regions of myelinated fibers of the central and peripheral nervous system. The most striking finding in MS lesions was the extension of decreased MAG immunostaining into white matter that appeared normal when treated with BP antiserum or luxol fast blue. In acute early MS lesions the decrease in MAG immunostaining extended far beyond the margin of acute demyelination, where the BP staining of degenerating sheaths often was increased. In chronic inactive plaques, this decrease in periaxonal MAG immunostaining was limited to relatively few fibers in a thin rim around each lesion. These observations suggest that in MS, immunoreactivity of periaxonal MAG is altered before myelin breakdown begins. Early in degeneration, myelin sheaths and their fragments often were more intensely stained by BP antiserum than normal sheaths; later the staining intensity decreased. In shadow plaques, BP antiserum stained some oligodendroglia. Their appearance and location among thinly myelinated axons suggested that these oligondendroglia were forming new sheaths around previously demyelinated axons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sternberger, N. H., Itoyama, Y., Kies, M. W., & Webster, H. D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.5.2521 · Cited by 270
Self-citation
Cited by
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185
Oligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757
“This is consistent with the results of Itoyama et al, who found MBP immunohistochemistry to be more sensitive than LFB histochemistry, particularly for the detection of cortical MS lesions (16).”
ResultDistinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Kruse, J., Mailhammer, R., Wernecke, H., Faissner, A., Sommer, I., Goridis, C., & Schachner, M. (1984) · Nature · doi:10.1038/311153a0 · Cited by 713
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., & Itoyama, Y. (2007) · Brain · doi:10.1093/brain/awm047 · Cited by 614
Self-citationThe J1 glycoprotein—a novel nervous system cell adhesion molecule of the L2/HNK-1 family
Kruse, J., Keilhauer, G., Faissner, A., Timpl, R., & Schachner, M. (1985) · Nature · doi:10.1038/316146a0 · Cited by 584
McFarlin, D. E., & McFarland, H. F. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211043071905 · Cited by 416
Mitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406
“A particular subtype of active multiple sclerosis lesions (Pattern III, Lucchinetti et al 2000), which are mainly found in patients with acute fulminant multiple sclerosis with Balo’s type concentric sclerosis and in a subset of early relapsing remitting multiple sclerosis, has been defined by the selective early loss…”
BackgroundWater content and myelin water fraction in multiple sclerosis
Laule, C., Vavasour, I. M., Moore, G. R. W., Oger, J., Li, D. K. B., Paty, D. W., & MacKay, A. L. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0306-6 · Cited by 369
Homogeneity of active demyelinating lesions in established multiple sclerosis
Breij, E. C. W., Brink, B. P., Veerhuis, R., van den Berg, C., Vloet, R., Yan, R., Dijkstra, C. D., van der Valk, P., & Bö, L. (2008) · Annals of Neurology · doi:10.1002/ana.21311 · Cited by 353
Insights into brain microstructure from the T2 distribution
MacKay, A., Laule, C., Vavasour, I., Bjarnason, T., Kolind, S., & Mädler, B. (2006) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2005.12.037 · Cited by 347
Magnetic Resonance Imaging of Myelin
Laule, C., Vavasour, I. M., Kolind, S. H., Li, D. K. B., Traboulsee, T. L., Moore, G. R. W., & MacKay, A. L. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.05.004 · Cited by 334
Aboul-Enein, F., Rauschka, H., Kornek, B., Stadelmann, C., Stefferl, A., Brück, W., Lucchinetti, C., Schmidbauer, M., Jellinger, K., & Lassmann, H. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.25 · Cited by 330
Myelin‐associated glycoprotein (MAG): past, present and beyond
Quarles, R. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04319.x · Cited by 326
Self-citationLai, C., Brow, M. A., Nave, K. A., Noronha, A. B., Quarles, R. H., Bloom, F. E., Milner, R. J., & Sutcliffe, J. G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.12.4337 · Cited by 318
Self-citationTheiler's Virus Infection: a Model for Multiple Sclerosis
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., & Platsoucas, C. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.174-207.2004 · Cited by 308
Myelin‐Associated Glycoprotein Is the Antigen for a Monoclonal IgM in Polyneuropathy
Braun, P. E., Frail, D. E., & Latov, N. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb12563.x · Cited by 304
Magnetic Resonance of Myelin Water: An in vivo Marker for Myelin
MacKay, A. L., & Laule, C. (2016) · Brain Plasticity · doi:10.3233/bpl-160033 · Cited by 284
Ilyas, A. A., Quarles, R. H., MacIntosh, T. D., Dobersen, M. J., Trapp, B. D., Dalakas, M. C., & Brady, R. O. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1225 · Cited by 260
Self-citationOligodendrocytes in the early course of multiple sclerosis
Brück, W., Schmied, M., Suchanek, G., Brück, Y., Breitschopf, H., Poser, S., Piddlesden, S., & Lassmann, H. (1994) · Annals of Neurology · doi:10.1002/ana.410350111 · Cited by 216
Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis
Papadopoulos, D., Dukes, S., Patel, R., Nicholas, R., Vora, A., & Reynolds, R. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00177.x · Cited by 192
Brink, B. P., Veerhuis, R., Breij, E. C. W., van der Valk, P., Dijkstra, C. D., & Bö, L. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.147 · Cited by 191
Oligodendrocytes and the early multiple sclerosis lesion
Prineas, J. W., & Parratt, J. D. E. (2012) · Annals of Neurology · doi:10.1002/ana.23634 · Cited by 149
Immunocytochemical localization of the myelin-associated glycoprotein Fact or Artifact?
Trapp, B. D., & Quarles, R. H. (1984) · Journal of Neuroimmunology · doi:10.1016/0165-5728(84)90011-0 · Cited by 105
Self-citationBiochemically altered myelin triggers autoimmune demyelination
Caprariello, A. V., Rogers, J. A., Morgan, M. L., Hoghooghi, V., Plemel, J. R., Koebel, A., Tsutsui, S., Dunn, J. F., Kotra, L. P., Ousman, S. S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721115115 · Cited by 104
THE PATHOLOGY OF MULTIPLE SCLEROSIS‐FACT, FICTION AND HYPOTHESIS
ALLEN, I. V. (1981) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1981.tb00087.x · Cited by 58
Kolind, S. H., Laule, C., Vavasour, I. M., Li, D. K. B., Traboulsee, A. L., Mädler, B., Moore, G. R. W., & MacKay, A. L. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.11.033 · Cited by 44
“Thus, it is likely that there are pathological processes taking place that are not visible on conventional MR images; histopathological studies of white matter have shown inflammation, demyelination and astrocyte proliferation where no lesion or other macroscopically visible anomaly is present (Allen et al., 2001; All…”
BackgroundSIGLEC-4 (MAG) antagonists: From the natural carbohydrate epitope to glycomimetics
Schwardt, O., Kelm, S., & Ernst, B. (2013) · Topics in current chemistry · doi:10.1007/128_2013_498 · Cited by 14
Metadata
- Authors
- Itoyama, Y., Sterhberger, N. H., Webster, H. D., Quarles, R. H., Cohen, S. R., & Richardson, E. P.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1980-02
- Volume
- 7
- Issue
- 2
- Pages
- 167-177
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2110662341
- Cited by
- 241
- References
- 1
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.